POS7 COST-EFFECTIVENESS SIMULATION MODELING OF THE COMPLIANCE OF 5 MG ZOLEDRONIC ACID ONCE A YEAR VERSUS CURRENT TREATMENTS IN POST-MENOPAUSAL OSTEOPOROSIS
Abstract
Authors
P Fardellone B Cortet T Thomas E Legrand X Bresse S Bisot-Locard A Beresniak